Texas Weight Loss - Houston Kirby

Texas Weight Loss - Houston Kirby operates under the medical direction of Dr. Joseph Sleiman, FAAFP, providing evidence-based medical weight loss programs in Houston, Texas. The clinic focuses exclusively on physician-supervised weight management, utilizing GLP-1 receptor agonist peptides alongside structured dietary protocols and metabolic optimization strategies. Dr. Sleiman's board certification in Family Medicine through the American Academy of Family Physicians informs the clinic's comprehensive approach to addressing obesity as a chronic metabolic condition rather than a lifestyle failure. Patients at the Houston Kirby location receive individualized treatment plans that account for metabolic rate, hormonal factors, medication interactions, and comorbid conditions such as prediabetes, hypertension, and fatty liver disease.

The clinic's peptide therapy program centers on two FDA-approved GLP-1 medications: Semaglutide and Tirzepatide. Semaglutide, a glucagon-like peptide-1 receptor agonist, works by mimicking incretin hormones that regulate insulin secretion and appetite signaling in the hypothalamus. Tirzepatide represents a dual-agonist approach, targeting both GLP-1 and GIP receptors to enhance glycemic control and promote satiety through multiple metabolic pathways. Texas Weight Loss administers these peptides via subcutaneous injection on a weekly schedule, with dosing titrated based on individual tolerance and response. The medical team monitors patients for common side effects including nausea, constipation, and injection site reactions, adjusting protocols as needed to maintain therapeutic benefit while minimizing discomfort. Both medications require ongoing medical supervision due to contraindications in patients with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.

Dr. Sleiman's clinical model integrates peptide therapy with structured nutritional counseling and behavioral modification strategies. Initial consultations include comprehensive metabolic assessment, body composition analysis, and review of previous weight loss attempts to identify physiological barriers to success. The dietary guidance component emphasizes macronutrient balance, meal timing, and sustainable eating patterns rather than restrictive dieting. Patients receive specific caloric targets and food selection guidelines tailored to their metabolic profile and medication regimen, as GLP-1 agonists significantly alter appetite and gastric emptying rates. The clinic's approach recognizes that peptide therapy produces optimal results when combined with dietary protein adequacy to preserve lean muscle mass during weight reduction phases.

Patients at Texas Weight Loss - Houston Kirby follow a structured monitoring protocol that includes regular weigh-ins, progress assessments, and medication adjustments throughout their treatment course. The clinic schedules follow-up visits at intervals determined by individual response patterns and medication titration schedules, typically every two to four weeks during the initial phase. Dr. Sleiman and his medical staff track not only weight changes but also improvements in metabolic markers, medication requirements for comorbid conditions, and patient-reported quality of life measures. The program addresses common challenges such as weight loss plateaus, medication tolerance issues, and the transition to maintenance dosing once goal weight ranges are achieved. Patients work directly with the medical team to develop long-term weight maintenance strategies that may include continued peptide therapy at reduced doses or transition to lifestyle-based maintenance protocols.

The Houston Kirby clinic offers both in-person consultations at their Houston facility and telehealth appointments for patients throughout Texas, providing flexibility for initial assessments and ongoing follow-up care. Telehealth visits allow patients across Texas to access Dr. Sleiman's medical weight loss expertise without geographic limitations, with medications shipped directly to patient addresses and virtual check-ins conducted via secure video platform. In-person visits at the Houston location include body composition testing and hands-on injection training for patients new to self-administered peptide therapy. The clinic's dual-modality approach accommodates varying patient preferences and schedules while maintaining the medical oversight essential for safe GLP-1 agonist therapy. Texas Weight Loss accepts various payment options for their medical weight loss programs, with specific pricing provided during initial consultations based on individual treatment plans and medication selection.